Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure?

被引：1
|
作者：
Ernest-Suarez, Kenneth [1 ]
Lu, Cathy [1 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 06期
关键词：
D O I：
10.1111/apt.17351
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：733 / 734
页数：2
相关论文
共 48 条
  • [31] COMPARATIVE EFFECTIVENESS OF ORAL JANUS KINASE INHIBITORS VERSUS VEDOLIZUMAB IN ULCERATIVE COLITIS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Akhras, Aya
    Abu-Rumaileh, Mohammed
    Abbarh, Shahem
    Sawaf, Bisher
    Albandak, Maram
    Rabeeah, Sana
    Hallak, Yusuf O.
    Alhayek, Mohammad
    Alastal, Yaseen
    Dahhan, Wael
    INFLAMMATORY BOWEL DISEASES, 2025, 31 : S8 - S8
  • [32] MEDICAL AND NON-MEDICAL REASONS FOR DISCONTINUATION OF ANTI-TNF AGENTS AMONG PATIENTS WITH ULCERATIVE COLITIS IN REAL-WORLD SETTING: A SYSTEMATIC REVIEW
    Gutta, D.
    Gautam, R.
    Prasanna, R.
    Rai, M. K.
    VALUE IN HEALTH, 2022, 25 (12) : S26 - S26
  • [33] Anti-TNF therapy for Ulcerative Colitis in Brazil: a comparative real-world national multicentric study from the Brazilian Study Group of IBD (GEDIIB)
    Sassaki, L. Y.
    Magro, D. O.
    Saad-Hossne, R.
    Baima, J. P.
    Flores, C.
    Correia, L. P. D. M. P.
    Ferrari, M. D. L. D. A.
    Zacharias, P.
    Feitosa, M. R.
    Santos, C. H. M.
    Lins Neto, M. A. D. F.
    Quaresma, A. B.
    Lima Junior, S. F.
    Vasconcelos, G. B. S.
    Cassol, O.
    Pinto, A. D. S.
    Kurachi, G.
    Goncalves Filho, F. D. A.
    Gasparini, R. G.
    Furlan, T. K.
    Catapani, W.
    Coy, C. S. R.
    Menegassi, V. D. S.
    Colombo, M. M.
    Froes, R. D. S. B.
    Teixeira, F. V.
    Moraes, A. C.
    Santana, G. O.
    Parente, J. M. L.
    Vilela, E. G.
    Kotze, P. G.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S540 - S541
  • [34] Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study
    Hupe, M.
    Streichenberger, A.
    Wils, P.
    Arab, N.
    Serrero, M.
    Amiot, A.
    Bozon, A.
    Vuitton, L.
    Fumery, M.
    Altwegg, R.
    Nachury, M.
    Hebuterne, X.
    Yzet, C.
    Coban, D.
    Dodel, M.
    Bazoge, M.
    Pereira, B.
    Buisson, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (08) : 1312 - 1318
  • [35] Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
    Sassaki, Ligia Yukie
    Magro, Daniela Oliveira
    Saad-Hossne, Rogerio
    Baima, Julio Pinheiro
    Flores, Cristina
    Correia, Lucianna Motta
    Soares Celani, Livia Medeiros
    De Abreu Ferrari, Maria De Lourdes
    Zacharias, Patricia
    Feitosa, Marley Ribeiro
    Marques Dos Santos, Carlos Henrique
    De Freitas Lins Neto, Manoel Alvaro
    Quaresma, Abel Botelho
    De Lima Junior, Sergio Figueiredo
    Salgado De Vasconcelos, Graciana Bandeira
    Cassol, Ornella Sari
    Pinto, Arlene Dos Santos
    Kurachi, Gustavo
    Goncalves Filho, Francisco de Assis
    Gasparini, Rodrigo Galhardi
    Furlan, Thaisa Kowalski
    Catapani, Wilson Roberto
    Rodrigues Coy, Claudio Saddy
    Menegassi, Vivian De Souza
    Colombo, Marilia Majeski
    Froes, Renata de Sa Brito
    Teixeira, Fabio Vieira
    Moraes, Antonio Carlos
    Santana, Genoile Oliveira
    Luz Parente, Jose Miguel
    Vilela, Eduardo Garcia
    Freitas Queiroz, Natalia Sousa
    Kotze, Paulo Gustavo
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [36] Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
    Ligia Yukie Sassaki
    Daniela Oliveira Magro
    Rogerio Saad-Hossne
    Julio Pinheiro Baima
    Cristina Flores
    Lucianna Motta Correia
    Lívia Medeiros Soares Celani
    Maria De Lourdes De Abreu Ferrari
    Patricia Zacharias
    Marley Ribeiro Feitosa
    Carlos Henrique Marques Dos Santos
    Manoel Alvaro De Freitas Lins Neto
    Abel Botelho Quaresma
    Sergio Figueiredo De Lima Junior
    Graciana Bandeira Salgado De Vasconcelos
    Ornella Sari Cassol
    Arlene Dos Santos Pinto
    Gustavo Kurachi
    Francisco de Assis Goncalves Filho
    Rodrigo Galhardi Gasparini
    Thaísa Kowalski Furlan
    Wilson Roberto Catapani
    Cláudio Saddy Rodrigues Coy
    Vivian De Souza Menegassi
    Marilia Majeski Colombo
    Renata de Sá Brito Fróes
    Fabio Vieira Teixeira
    Antonio Carlos Moraes
    Genoile Oliveira Santana
    José Miguel Luz Parente
    Eduardo Garcia Vilela
    Natália Sousa Freitas Queiroz
    Paulo Gustavo Kotze
    BMC Gastroenterology, 22
  • [37] COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB VS ANTI-TNFs IN ULCERATIVE COLITIS BIO-NAIVE PATIENTS AND PATIENTS WITH FAILURE OF ONE PREVIOUS ANTI-TNFα (EVOLVE-IBERIA STUDY)
    Casellas Jorda, F.
    Rodriguez, C.
    Gisbert, J. P.
    Bernardo, S.
    Aparicio, J.
    Tagarro, I.
    Munoz, F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 912 - 913
  • [38] Superior treatment persistence with ustekinumab in Crohn's disease and vedolizumab in ulcerative colitis compared with anti-TNF biological agents: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
    Ko, Yanna
    Paramsothy, Sudarshan
    Yau, Yunki
    Leong, Rupert W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (03) : 292 - 301
  • [39] Real-world comparison of effectiveness between ustekinumab and a second anti-TNF agent in patients with symptomatic stenosing Crohn's disease after failure of a first anti-TNF agent: results of the USTEKNOSIS study
    Buisson, A.
    Jammet, A.
    Pereira, B.
    Fumery, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 562 - 564
  • [40] REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN USTEKINUMAB AND A SECOND ANTI-TNF AGENT IN PATIENTS WITH SYMPTOMATIC STENOSING CROHN'S DISEASE AFTER FAILURE OF A FIRST ANTI-TNF AGENT: RESULTS OF THE USTEKNOSIS STUDY
    Buisson, Anthony
    Jammet, Arthur
    Pereira, Bruno
    Fumery, Mathurin
    GASTROENTEROLOGY, 2023, 164 (06) : S648 - S648
12345